Literature DB >> 30802426

Risk factors of severe imported malaria in Anhui province, China.

Tao Zhang1, Xian Xu2, Jingjing Jiang3, Chen Yu4, Cuicui Tian5, Qinxiu Xie6, Weidong Li7.   

Abstract

We aimed to determine risk factors for developing severe illness in patients infected with imported Plasmodium falciparum, and identify factors that can be implemented in preventive public health actions. Data of patients in Anhui province were collected from the China Information System for Disease Control and Prevention and Information System for Parasitic Disease Control and Prevention from 2012 to 2018. Epidemiological characteristics, clinical severity, and preventive measures were analyzed using descriptive statistics. Risk factors for severe malaria were identified by logistic regression. During the study period, 8.01% (53/662) of patients infected with P. falciparum developed severe malaria; the annual severe incidence rate varied from 5.93% to 10.77% and the fatality rate was 0.6%. Two models were built to analyze the delay from symptom onset to treatment; one analyzed data by stage, whereas the other analyzed data combined from all stages. In model 1, multivariate analysis identified misdiagnosis at first medical visit and patient delay as risk factors for severe malaria (odds ratio: 3.108 and 3.385, respectively, all p < 0.01). In model 2, overall delay was a significant factor of severe malaria onset (odds ratio: 4.719, p = 0.000). In both models, patients with a history of previous infection had a significantly reduced risk of developing severe malaria; high parasitemia (≥2.5%) was associated with an increased risk of severe infection. Delay between symptom onset and treatment was an important cause for development of severe disease in Anhui province. Measures to reduce delays should be used and implemented in preventive public health actions.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anhui province; Imported; Plasmodium falciparum; Severe malaria

Mesh:

Year:  2019        PMID: 30802426     DOI: 10.1016/j.actatropica.2019.02.020

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Problems Associated with the Diagnosis of Imported Malaria in Anhui Province, China.

Authors:  Weidong Li; Tao Zhang; Xian Xu; Jingjing Jiang; Chen Yu; Cuicui Tian; Shuqi Wang; Xiaofeng Lyu; Zhirong Liu
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

2.  Epidemiological profile of Plasmodium ovale spp. imported from Africa to Anhui Province, China, 2012-2019.

Authors:  Tao Zhang; Shuqi Wang; Duoquan Wang; Sarah Auburn; Shenning Lu; Xian Xu; Jingjing Jiang; Xiaofeng Lyu; Chen Yu; Cuicui Tian; Shizhu Li; Weidong Li
Journal:  Malar J       Date:  2021-01-06       Impact factor: 2.979

3.  Malaria Risk Map Using Spatial Multi-Criteria Decision Analysis along Yunnan Border During the Pre-elimination Period.

Authors:  Xiaotao Zhao; Weerapong Thanapongtharm; Siam Lawawirojwong; Chun Wei; Yerong Tang; Yaowu Zhou; Xiaodong Sun; Liwang Cui; Jetsumon Sattabongkot; Jaranit Kaewkungwal
Journal:  Am J Trop Med Hyg       Date:  2020-06-25       Impact factor: 2.345

4.  Management of imported malaria cases and healthcare institutions in central China, 2012-2017: application of decision tree analysis.

Authors:  Xi-Liang Wang; Jie-Bin Cao; Dan-Dan Li; Dong-Xiao Guo; Cheng-Da Zhang; Xiao Wang; Dan-Kang Li; Qing-Lin Zhao; Xiao-Wen Huang; Wei-Dong Zhang
Journal:  Malar J       Date:  2019-12-18       Impact factor: 2.979

5.  Risk factors for the accuracy of the initial diagnosis of malaria cases in China: a decision-tree modelling approach.

Authors:  Gang Li; Donglan Zhang; Zhuo Chen; Da Feng; Xinyan Cai; Xiaoyu Chen; Shangfeng Tang; Zhanchun Feng
Journal:  Malar J       Date:  2022-01-07       Impact factor: 2.979

6.  Surveillance and Response to Imported Malaria During the COVID-19 Epidemic - Anhui Province, China, 2019-2021.

Authors:  Tao Zhang; Jingjing Jiang; Xiaofeng Lyu; Xian Xu; Shuqi Wang; Zijian Liu; Jianhai Yin; Weidong Li
Journal:  China CDC Wkly       Date:  2022-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.